Central nervous system TNFα-mRNA expression during rabbit experimental pneumococcal meningitis

Neuroscience Letters

Volumn 237, Issue 2-3, 1997, Pages 105-108

  Bitsch, A ^a   Trostdorf, F ^a   Bruck W ^a   Schmidt, H ^a   Fischer, F R ^b   Nau, R ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Meningitis; Monocytes; Streptococcus pneumonia; Tumor necrosis factor alpha

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; CELLULAR DISTRIBUTION; CHOROID PLEXUS; CONTROLLED STUDY; IMMUNOMODULATION; IN SITU HYBRIDIZATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; CENTRAL NERVOUS SYSTEM; IN SITU HYBRIDIZATION; MENINGITIS, PNEUMOCOCCAL; MONOCYTES; RABBITS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031438065     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00830-6     Document Type: Article

References (20)

1. Bass R., Engelhard D., Trembovler V., Shohami E. A novel non-psychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis. J. Infect. Dis. 173:1996;735-738.
2. Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor beta and interleukin-10. J. Biol. Chem. 267:1992;23301-23308.
3. Breitschopf H., Suchanek G., Gould R.M., Coleman D.R., Lassmann H. In situ hybridization with digoxigenine-labelled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol. (Berl.). 84:1992;581-587.
4. Burroughs M.H., Tsenova Berkova L., Sokol K., Ossig J., Tuomanen E., Kaplan G. Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental bacterial meningitis. Microb. Pathogenesis. 19:1995;245-255.
5. Diab A., Zhu J., Lindquist L., Wretlind B., Bakhiet M., Link H. Haemophilus influenzae and Streptococcus pneumoniae induce different intracerebral mRNA cytokine patterns during the course of experimental bacterial meningitis. Clin. Exp. Immunol. 109:1997;233-241.
6. Freyer D., Weih M., Weber J.R., Burger W., Scholz P., Manz R., Ziegenhorn A., Angstwurm K., Dirnagl U. Pneumococcal cell wall components induce nitric oxide synthase and TNF-alpha in astroglial-enriched cultures. Glia. 16:1996;1-6.
7. Ito H., Shirai T., Yamamoto S., Akira M., Kawahara S., Todd C.W., Wallace B.W. Molecular cloning of the gene encoding for rabbit tumor necrosis factor. DNA. 5:1986;157-165.
8. Logel J., Dill D., Leonard S. Synthesis of cRNA probes from PCR-generated DNA. Biotechniques. 13:1992;604-610.
9. Ossege L.M., Sindern E., Voss B., Malin J.P. Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in cerebrospinal fluid cells in meningitis. J. Neurol. Sci. 144:1996;1-13.
10. Ramilo O., Saez-Llorens X., Mertsola J., Jafari H., Olsen K.D., Hansen E.J., Yoshinaga M., Ohkawara S., Nariuchi H., McCracken G.H. Jr. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J. Exp. Med. 172:1990;497-507.
11. Saukkonen K., Sande S., Cioffe C., Wolpe S., Sherry B., Cerami A., Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171:1990;439-448.
12. Sharief M.K., Ciardi M., Thompson E.J. Blood-brain barrier damage in patients with bacterial meningitis: association with tumor necrosis factor-alpha but not interleukin-1 beta. J. Infect. Dis. 166:1992;350-358.
13. Stearman M., Southgate H.J. The use of cytokine and C-reactive protein measurements in cerebrospinal fluid during acute infective meningitis. Ann. Clin. Biochem. 31:1994;255-261.
14. Tarlow M.J., Jenkins R., Comis S.D., Osborne M.P., Stephens S., Stanley P., Crocker J. Ependymal cells of the choroid plexus express tumour necrosis factor-alpha. Neuropathol. Appl. Neurobiol. 19:1993;324-328.
15. Täuber M.G., Sachdeva M., Kennedy S.L., Loetscher H., Lesslauer W. Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram-negative meningitis. J. Infect. Dis. 166:1992;1045-1050.
16. Tuomanen E. Adjunctive therapy of experimental meningitis: agents other than steroids. Antibiot. Chemother. 45:1992;184-191.
17. Tuomanen E.I. Molecular and cellular mechanisms of pneumococcal meningitis. Ann. N. Y. Acad. Sci. 797:1996;42-52.
18. Tureen J. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide. J. Clin. Invest. 95:1995;1086-1091.
19. Zysk G., Brück W., Fischer F.R., Mäder M., Rieckmann P., Nau R. Limited efficacy of pentoxifylline as anti-inflammatory agent in experimental pneumococcal meningitis. Clin. Exp. Immunol. 107:1997;458-461.
20. Zysk G., Brück W., Huitinga l., Fischer F.R., Flachsbarth F., van Rooijen N., Nau R. Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis. J. Neuroimmunol. 73:1997;77-80.